These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 9398056)
1. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator. Tiberio A; Farina AR; Tacconelli A; Cappabianca L; Gulino A; Mackay AR Int J Cancer; 1997 Nov; 73(5):740-8. PubMed ID: 9398056 [TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells. Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Farina AR; Coppa A; Tiberio A; Tacconelli A; Turco A; Colletta G; Gulino A; Mackay AR Int J Cancer; 1998 Mar; 75(5):721-30. PubMed ID: 9495240 [TBL] [Abstract][Full Text] [Related]
4. Detection of matrix metalloproteinases (MMP), tissue inhibitor of metalloproteinase-2, urokinase and plasminogen activator inhibitor-1 within matrigel and growth factor-reduced matrigel basement membrane. Gillette KM; Forbes K; Sehgal I Tumori; 2003; 89(4):421-5. PubMed ID: 14606648 [TBL] [Abstract][Full Text] [Related]
5. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Festuccia C; Guerra F; D'Ascenzo S; Giunciuglio D; Albini A; Bologna M Int J Cancer; 1998 Jan; 75(3):418-31. PubMed ID: 9455804 [TBL] [Abstract][Full Text] [Related]
6. Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. Taguchi K; Yoshida K; Sasaki F; Fujinaga K Jpn J Cancer Res; 1997 Apr; 88(4):394-400. PubMed ID: 9197532 [TBL] [Abstract][Full Text] [Related]
7. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells. Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599 [TBL] [Abstract][Full Text] [Related]
9. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. Hudson MA; McReynolds LM J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186 [TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Jacob K; Wach F; Holzapfel U; Hein R; Lengyel E; Buettner R; Bosserhoff AK Melanoma Res; 1998 Jun; 8(3):211-9. PubMed ID: 9664142 [TBL] [Abstract][Full Text] [Related]
11. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel. Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431 [TBL] [Abstract][Full Text] [Related]
12. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity. Tsuboi R; Rifkin DB Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142 [TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302 [TBL] [Abstract][Full Text] [Related]
15. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Webber MM; Waghray A Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
18. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. García de Veas R; Schweigerer L; Medina MA Eur J Cancer; 1998 Oct; 34(11):1736-40. PubMed ID: 9893662 [TBL] [Abstract][Full Text] [Related]
20. Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobases. Bulens F; Ibañez-Tallon I; Van Acker P; De Vriese A; Nelles L; Belayew A; Collen D J Biol Chem; 1995 Mar; 270(13):7167-75. PubMed ID: 7706255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]